{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:34Z","timestamp":1790638654195,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01 EB003268"],"award-info":[{"award-number":["R01 EB003268"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["FRN 119312"],"award-info":[{"award-number":["FRN 119312"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85811-8","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:11:08Z","timestamp":1736935868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MRI-guided focused ultrasound for treating Parkinson\u2019s disease with human mesenchymal stem cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Sheng-Kai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kullervo","family":"Hynynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"85811_CR1","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.3233\/JPD-181488","volume":"8","author":"C Henchcliffe","year":"2018","unstructured":"Henchcliffe, C. & Parmar, M. Repairing the brain: cell replacement using stem cell-based technologies. J. Parkinsons Dis. 8, S131\u2013S137 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"85811_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/NRL.0b013e3181be6d15","volume":"16","author":"KD Sethi","year":"2010","unstructured":"Sethi, K. D. The impact of levodopa on quality of life in patients with Parkinson disease. Neurologist 16, 76\u201383 (2010).","journal-title":"Neurologist"},{"key":"85811_CR3","first-page":"S40","volume":"55","author":"AL Benabid","year":"2000","unstructured":"Benabid, A. L. et al. Deep brain stimulation of the subthalamic nucleus for Parkinson\u2019s disease: methodologic aspects and clinical criteria. Neurology 55, S40\u2013S44 (2000).","journal-title":"Neurology"},{"key":"85811_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/ana.10517","volume":"53","author":"JL Vitek","year":"2003","unstructured":"Vitek, J. L. et al. Randomized trial of pallidotomy versus medical therapy for Parkinson\u2019s disease. Ann. Neurol. 53, 558\u2013569 (2003).","journal-title":"Ann. Neurol."},{"key":"85811_CR5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/jcp.27182","volume":"234","author":"S Bagheri-Mohammadi","year":"2019","unstructured":"Bagheri-Mohammadi, S. et al. Stem cell-based therapy for Parkinson\u2019s disease with a focus on human endometrium-derived mesenchymal stem cells. J. Cell. Physiol. 234, 1326\u20131335 (2019).","journal-title":"J. Cell. Physiol."},{"key":"85811_CR6","doi-asserted-by":"crossref","unstructured":"Burgess, A. et al. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS One 6, (2011).","DOI":"10.1371\/journal.pone.0027877"},{"key":"85811_CR7","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1177\/0963689717715824","volume":"26","author":"W Shen","year":"2017","unstructured":"Shen, W. et al. Magnetic enhancement of stem cell\u2013targeted delivery into the brain following MR-guided focused ultrasound for opening the blood\u2013brain barrier. Cell. Transpl. 26, 1235\u20131246 (2017).","journal-title":"Cell. Transpl."},{"key":"85811_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees, J. L., Lee, R. H. & Gregory, C. A. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell. Res. Ther. 7, 125 (2016).","journal-title":"Stem Cell. Res. Ther."},{"key":"85811_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s10072-020-04240-9","volume":"41","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Shen, J., Ke, K. & Gu, X. Clinical potential and current progress of mesenchymal stem cells for Parkinson\u2019s disease: a systematic review. Neurol. Sci. 41, 1051\u20131061 (2020).","journal-title":"Neurol. Sci."},{"key":"85811_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","volume":"155","author":"NK Venkataramana","year":"2010","unstructured":"Venkataramana, N. K. et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson\u2019s disease. Transl Res. 155, 62\u201370 (2010).","journal-title":"Transl Res."},{"key":"85811_CR11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","volume":"344","author":"CR Freed","year":"2001","unstructured":"Freed, C. R. et al. Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N Engl. J. Med. 344, 710\u2013719 (2001).","journal-title":"N Engl. J. Med."},{"key":"85811_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","volume":"54","author":"CW Olanow","year":"2003","unstructured":"Olanow, C. W. et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease. Ann. Neurol. 54, 403\u2013414 (2003).","journal-title":"Ann. Neurol."},{"key":"85811_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","volume":"12","author":"RA Barker","year":"2013","unstructured":"Barker, R. A., Barrett, J., Mason, S. L. & Bj\u00f6rklund, A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson\u2019s disease. Lancet Neurol. 12, 84\u201391 (2013).","journal-title":"Lancet Neurol."},{"key":"85811_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0166-2236(93)90180-T","volume":"16","author":"VH Perry","year":"1993","unstructured":"Perry, V. H., Andersson, P. B. & Gordon, S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16, 268\u2013273 (1993).","journal-title":"Trends Neurosci."},{"key":"85811_CR15","first-page":"902","volume":"5","author":"JD Sinden","year":"1992","unstructured":"Sinden, J. D., Patel, S. N. & Hodges, H. Neural transplantation: problems and prospects for therapeutic application. Curr. Opin. Neurol. Neurosurg. 5, 902\u2013908 (1992).","journal-title":"Curr. Opin. Neurol. Neurosurg."},{"key":"85811_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2010.1130","volume":"14","author":"L Danielyan","year":"2011","unstructured":"Danielyan, L. et al. Therapeutic efficacy of Intranasally delivered mesenchymal stem cells in a rat model of Parkinson Disease. Rejuvenation Res. 14, 3\u201316 (2011).","journal-title":"Rejuvenation Res."},{"key":"85811_CR17","doi-asserted-by":"publisher","first-page":"e27877","DOI":"10.1371\/journal.pone.0027877","volume":"6","author":"A Burgess","year":"2011","unstructured":"Burgess, A. et al. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS One. 6, e27877\u2013e27877 (2011).","journal-title":"PLoS One"},{"key":"85811_CR18","doi-asserted-by":"publisher","first-page":"101726","DOI":"10.1016\/j.scr.2020.101726","volume":"43","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Non-invasively enhanced intracranial transplantation of mesenchymal stem cells using focused ultrasound mediated by overexpression of cell-adhesion molecules. Stem Cell. Res. 43, 101726 (2020).","journal-title":"Stem Cell. Res."},{"key":"85811_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1750-3639.2012.00628.x","volume":"23","author":"J Guan","year":"2013","unstructured":"Guan, J. et al. Vascular degeneration in Parkinson\u2019s Disease. Brain Pathol. 23, 154 (2013).","journal-title":"Brain Pathol."},{"key":"85811_CR20","doi-asserted-by":"crossref","unstructured":"Cova, L. et al. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson\u2019s disease. Brain Res. 1311, (2010).","DOI":"10.1016\/j.brainres.2009.11.041"},{"key":"85811_CR21","doi-asserted-by":"publisher","unstructured":"Krampera, M. et al. Regenerative and immunomodulatory potential of mesenchymal stem cells. Current Opinion in Pharmacology vol. 6 Preprint at (2006). https:\/\/doi.org\/10.1016\/j.coph.2006.02.008","DOI":"10.1016\/j.coph.2006.02.008"},{"key":"85811_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/931902","author":"NK Venkataramana","year":"2012","unstructured":"Venkataramana, N. K. et al. Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson\u2019s disease: a pilot clinical study. Stem Cells Int. https:\/\/doi.org\/10.1155\/2012\/931902 (2012).","journal-title":"Stem Cells Int."},{"key":"85811_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.5966\/sctm.2015-0023","volume":"4","author":"S Cerri","year":"2015","unstructured":"Cerri, S. et al. Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson\u2019s Disease, focusing on cell distribution and neuroprotective and behavioral effects. Stem Cells Transl Med. 4, 1073\u20131085 (2015).","journal-title":"Stem Cells Transl Med."},{"key":"85811_CR24","doi-asserted-by":"crossref","unstructured":"Prockop, D. J. et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12, (2010).","DOI":"10.3109\/14653249.2010.507330"},{"key":"85811_CR25","doi-asserted-by":"crossref","unstructured":"le Blanc, K. Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 8, (2006).","DOI":"10.1080\/14653240601045399"},{"key":"85811_CR26","doi-asserted-by":"publisher","unstructured":"Glavaski-Joksimovic, A. & Bohn, M. C. Mesenchymal stem cells and neuroregeneration in Parkinson\u2019s disease. Experimental Neurology vol. 247 Preprint at (2013). https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.016","DOI":"10.1016\/j.expneurol.2013.03.016"},{"key":"85811_CR27","doi-asserted-by":"crossref","unstructured":"Brazzini, A. et al. Intraarterial autologous implantation of adult stem cells for patients with Parkinson Disease. J. Vasc. Interv. Radiol. 21, 443\u2013451 (2010).","DOI":"10.1016\/j.jvir.2010.01.008"},{"key":"85811_CR28","doi-asserted-by":"crossref","unstructured":"Tsai, Y. A. et al. Treatment of spinocerebellar ataxia with mesenchymal stem cells: a phase I\/IIa clinical study. Cell. Transpl. 26, 503\u2013512 (2017).","DOI":"10.3727\/096368916X694373"},{"key":"85811_CR29","doi-asserted-by":"crossref","unstructured":"Lee, P. H. et al. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann. Neurol. 72, 32\u201340 (2012).","DOI":"10.1002\/ana.23612"},{"key":"85811_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scr.2010.09.005","volume":"6","author":"ABJ Prowse","year":"2011","unstructured":"Prowse, A. B. J., Chong, F., Gray, P. P. & Munro, T. P. Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell. Res. 6, 1\u201312 (2011).","journal-title":"Stem Cell. Res."},{"key":"85811_CR31","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1182\/blood-2006-05-025098","volume":"108","author":"B R\u00fcster","year":"2006","unstructured":"R\u00fcster, B. et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108, 3938\u20133944 (2006).","journal-title":"Blood"},{"key":"85811_CR32","doi-asserted-by":"crossref","unstructured":"Lee, J. et al. Non-invasively enhanced intracranial transplantation of mesenchymal stem cells using focused ultrasound mediated by overexpression of cell-adhesion molecules. Stem Cell. Res. 43, (2020).","DOI":"10.1016\/j.scr.2020.101726"},{"key":"85811_CR33","doi-asserted-by":"crossref","unstructured":"Burks, S. R. et al. Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model. PLoS One 6, (2011).","DOI":"10.1371\/journal.pone.0024730"},{"key":"85811_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3389\/fneur.2021.669449","volume":"12","author":"N Ahmed","year":"2021","unstructured":"Ahmed, N., Gandhi, D., Melhem, E. R. & Frenkel, V. MRI guided focused ultrasound-mediated delivery of therapeutic cells to the brain: a review of the state-of-the-art methodology and future applications. Front. Neurol. 12, 938 (2021).","journal-title":"Front. Neurol."},{"key":"85811_CR35","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/stem.1099","volume":"30","author":"A Ziadloo","year":"2012","unstructured":"Ziadloo, A. et al. Enhanced Homing Permeability and Retention of Bone Marrow Stromal cells by Noninvasive Pulsed focused Ultrasound. Stem Cells. 30, 1216\u20131227 (2012).","journal-title":"Stem Cells"},{"key":"85811_CR36","doi-asserted-by":"crossref","unstructured":"\u00c7avu\u015fo\u01e7lu, M. et al. Closed-loop cavitation control for focused ultrasound-mediated blood-brain barrier opening by long-circulating microbubbles. Phys. Med. Biol. 64, (2019).","DOI":"10.1088\/1361-6560\/aafaa5"},{"key":"85811_CR37","doi-asserted-by":"crossref","unstructured":"Arvanitis, C. D., Livingstone, M. S., Vykhodtseva, N. & McDannold, N. Controlled Ultrasound-Induced blood-brain barrier disruption using Passive Acoustic emissions Monitoring. PLoS One 7, (2012).","DOI":"10.1371\/journal.pone.0045783"},{"key":"85811_CR38","doi-asserted-by":"crossref","unstructured":"Bing, C. et al. Characterization of different bubble formulations for blood-brain barrier opening using a focused ultrasound system with acoustic feedback control. Sci. Rep. 8, (2018).","DOI":"10.1038\/s41598-018-26330-7"},{"key":"85811_CR39","doi-asserted-by":"publisher","first-page":"E10281","DOI":"10.1073\/pnas.1713328114","volume":"114","author":"T Sun","year":"2017","unstructured":"Sun, T. et al. Closed-loop control of targeted ultrasound drug delivery across the blood-brain\/tumor barriers in a rat glioma model. Proc. Natl. Acad. Sci. U S A. 114, E10281\u2013E10290 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"85811_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1148\/radiol.11111417","volume":"263","author":"MA O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly, M. A. & Hynynen, K. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 263, 96\u2013106 (2012).","journal-title":"Radiology"},{"key":"85811_CR41","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.7150\/thno.52710","volume":"11","author":"C Poon","year":"2021","unstructured":"Poon, C., Pellow, C. & Hynynen, K. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments. Theranostics 11, 1655\u20131671 (2021).","journal-title":"Theranostics"},{"key":"85811_CR42","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","volume":"22","author":"S Hersh","year":"2016","unstructured":"Hersh, S. Evolving drug delivery strategies to overcome the blood brain barrier. Curr. Pharm. Des. 22, 1177\u20131193 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"85811_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0733-8619(05)70373-X","volume":"16","author":"H Machkhas","year":"1998","unstructured":"Machkhas, H., Harati, Y. & SIDE EFFECTS OF IMMUNOSUPPRESSANT THERAPIES USED IN NEUROLOGY. Neurol. Clin. 16, 171\u2013188 (1998).","journal-title":"Neurol. Clin."},{"key":"85811_CR44","doi-asserted-by":"publisher","unstructured":"Stoker, T. B., Blair, N. F. & Barker, R. A. Neural grafting for Parkinson\u2019s disease: Challenges and prospects. Neural Regeneration Research vol. 12 Preprint at (2017). https:\/\/doi.org\/10.4103\/1673-5374.202935","DOI":"10.4103\/1673-5374.202935"},{"key":"85811_CR45","doi-asserted-by":"publisher","unstructured":"Jones, R. M. & Hynynen, K. R. Advances in acoustic monitoring and control of focused ultrasound-mediated increases in blood-brain barrier permeability. British Journal of Radiology vol. 92 Preprint at (2019). https:\/\/doi.org\/10.1259\/bjr.20180601","DOI":"10.1259\/bjr.20180601"},{"key":"85811_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7150\/thno.15987","volume":"7","author":"KH Song","year":"2017","unstructured":"Song, K. H. et al. Microbubble gas volume: a unifying dose parameter in blood-brain barrier opening by focused ultrasound. Theranostics 7, 144\u2013152 (2017).","journal-title":"Theranostics"},{"key":"85811_CR47","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1088\/0031-9155\/59\/20\/5987","volume":"59","author":"T Nhan","year":"2014","unstructured":"Nhan, T., Burgess, A., Lilge, L. & Hynynen, K. Modeling localized delivery of Doxorubicin to the brain following focused ultrasound enhanced blood-brain barrier permeability. Phys. Med. Biol. 59, 5987\u20136004 (2014).","journal-title":"Phys. Med. Biol."},{"key":"85811_CR48","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.ultrasmedbio.2012.04.015","volume":"38","author":"LH Treat","year":"2012","unstructured":"Treat, L. H., McDannold, N., Zhang, Y., Vykhodtseva, N. & Hynynen, K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med. Biol. 38, 1716 (2012).","journal-title":"Ultrasound Med. Biol."},{"key":"85811_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","volume":"84","author":"KM Sindhu","year":"2006","unstructured":"Sindhu, K. M. et al. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP\u2009+\u2009or rotenone display differential sensitivity to amphetamine and apomorphine. Pharmacol. Biochem. Behav. 84, 321\u2013329 (2006).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"85811_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2202-11-52","volume":"11","author":"F Wang","year":"2010","unstructured":"Wang, F. et al. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci. 11, 52 (2010).","journal-title":"BMC Neurosci."},{"key":"85811_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0091-3057(94)90469-3","volume":"49","author":"JL Hudson","year":"1994","unstructured":"Hudson, J. L., Fong, C. S., Boyson, S. J. & Hoffer, B. J. Conditioned apomorphine-induced turning in 6-OHDA-lesioned rats. Pharmacol. Biochem. Behav. 49, 147\u2013154 (1994).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"85811_CR52","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/stem.1415","volume":"31","author":"M Sundberg","year":"2013","unstructured":"Sundberg, M. et al. Improved cell therapy protocols for Parkinson\u2019s disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells. 31, 1548\u20131562 (2013).","journal-title":"Stem Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85811-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:11:19Z","timestamp":1736935879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85811-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85811"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85811-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.H. is a co-founder of FUS Instruments, a company that is commercializing the preclinical FUS system used in this work. S.-K. W, C.-L. T, and A. M. declare no competing interestst.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2029"}}